AVITA Medical (RCEL) Other Non-Current Liabilities (2019 - 2025)
AVITA Medical (RCEL) posted Other Non-Current Liabilities of $1.2 million for Q4 2025, down 33.17% on a QoQ basis from $1.9 million in Q3 2025, and down 58.57% year-over-year from $3.0 million in Q4 2024.
AVITA Medical (RCEL) Other Non-Current Liabilities (2019 - 2025) Analysis & Trends
AVITA Medical's Other Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $1.2 million for Q4 2025.
- Quarterly Other Non-Current Liabilities fell 58.57% year-over-year to $1.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.2 million (down 58.57% YoY) and the FY2025 annual result came in at $1.2 million, down 58.57% from the prior year.
- Other Non-Current Liabilities was $1.2 million for Q4 2025 at AVITA Medical, down from $1.9 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $4.0 million in Q1 2024 and bottomed at $19000.0 in Q1 2021.
- A 5-year average of $1.7 million and a median of $1.6 million in 2022 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2022 — Other Non-Current Liabilities jumped 2905.26% — and 2025, when it tumbled 58.57%.
- AVITA Medical's Other Non-Current Liabilities stood at $113000.0 in 2021, then jumped by 1092.92% to $1.3 million in 2022, then soared by 134.27% to $3.2 million in 2023, then fell by 5.0% to $3.0 million in 2024, then tumbled by 58.57% to $1.2 million in 2025.
- Business Quant data shows RCEL's Other Non-Current Liabilities at $1.2 million in Q4 2025, $1.9 million in Q3 2025, and $1.9 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | AVITA Medical | 140.94 Mn | 124.59 Mn | 14.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.24 Mn |
| Sep 30, 2025 | 1.86 Mn |
| Jun 30, 2025 | 1.90 Mn |
| Mar 31, 2025 | 3.05 Mn |
| Dec 31, 2024 | 3.00 Mn |
| Sep 30, 2024 | 2.76 Mn |
| Jun 30, 2024 | 1.97 Mn |
| Mar 31, 2024 | 4.03 Mn |
| Dec 31, 2023 | 3.16 Mn |
| Dec 31, 2022 | 1.35 Mn |
| Jun 30, 2022 | 715,000.00 |
| Mar 31, 2022 | 571,000.00 |
| Dec 31, 2021 | 113,000.00 |
| Sep 30, 2021 | 503,000.00 |
| Jun 30, 2021 | 503,000.00 |
| Mar 31, 2021 | 19,000.00 |
| Jun 30, 2019 | 42,000.00 |